Open Government Portal
Due to the COVID-19 pandemic, enhanced border measures authorized by the Quarantine Act were introduced to ensure appropriate actions …
Health Canada will also continue to identify and acquire COVID-19 treatments and therapies; expedite regulatory reviews of drugs, medical …
Health Canada and the Public Health Agency of Canada have been working with provinces, territories and other partners, including researchers, …
Canada and the Northwest Territories agree that immediate action and collaboration was and continues to be needed among governments to …
Guidance document provides applicants seeking authorization to conduct COVID-19 drug clinical trials specifically around the applications guidelines and process.
…IO No. 2 continues to support the optional pathway introduced by IO No. 1 to facilitate clinical trials for potential …
Learn more about drugs and vaccines being developed or authorized for COVID-19.
The purpose of this notice is to communicate the types of testing technologies that Health Canada considers are a priority …
During the pandemic, there may be more deviations from the established protocol. Despite this, it’s important to continue to protect …
The guidance documents contain information for applicants seeking authorization to conduct COVID-19 drug and medical device clinical trials under …